Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ticlopidine+Ginkgo Biloba Versus Clopidogrel in Clopidogrel Resistant Patients Undergoing Cartoid Artery Stent Placement

NCT02133989 is registered in ClinicalTrials.gov with Samsung Medical Center as lead sponsor.

NCT NCT02133989
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02133989 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ticlopidine+Ginkgo Biloba Versus Clopidogrel in Clopidogrel Resistant Patients Undergoing Cartoid Artery Stent Placement
Lead sponsor
Samsung Medical Center
Phase
Phase 3
Overall status
Unknown status
Start date
June 30, 2014
Completion date
December 31, 2017
Enrollment
86 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

carotid stenosis